A detailed history of Rock Springs Capital Management LP transactions in Exact Sciences Corp stock. As of the latest transaction made, Rock Springs Capital Management LP holds 1,147,500 shares of EXAS stock, worth $56.8 Million. This represents 2.66% of its overall portfolio holdings.

Number of Shares
1,147,500
Previous 1,081,500 6.1%
Holding current value
$56.8 Million
Previous $45.7 Million 71.0%
% of portfolio
2.66%
Previous 1.42%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$42.43 - $70.83 $2.8 Million - $4.67 Million
66,000 Added 6.1%
1,147,500 $78.1 Million
Q2 2024

Aug 14, 2024

BUY
$41.33 - $74.26 $898,927 - $1.62 Million
21,750 Added 2.05%
1,081,500 $45.7 Million
Q1 2024

May 15, 2024

BUY
$56.27 - $73.77 $2.26 Million - $2.97 Million
40,250 Added 3.95%
1,059,750 $73.2 Million
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $73,825 - $94,650
1,250 Added 0.12%
1,019,500 $75.4 Million
Q3 2023

Nov 14, 2023

BUY
$65.94 - $99.04 $4.93 Million - $7.4 Million
74,750 Added 7.92%
1,018,250 $69.5 Million
Q2 2023

Aug 14, 2023

BUY
$62.68 - $95.05 $125,360 - $190,100
2,000 Added 0.21%
943,500 $88.6 Million
Q1 2023

May 15, 2023

BUY
$47.19 - $70.77 $2.55 Million - $3.82 Million
54,000 Added 6.08%
941,500 $63.8 Million
Q4 2022

Feb 14, 2023

BUY
$30.35 - $53.15 $9.38 Million - $16.4 Million
308,900 Added 53.39%
887,500 $43.9 Million
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $188,623 - $291,283
5,900 Added 1.03%
578,600 $18.8 Million
Q2 2022

Aug 15, 2022

BUY
$35.61 - $76.23 $96,147 - $205,821
2,700 Added 0.47%
572,700 $22.6 Million
Q1 2021

May 17, 2021

BUY
$116.57 - $155.01 $9.91 Million - $13.2 Million
85,000 Added 17.53%
570,000 $75.1 Million
Q4 2020

Feb 16, 2021

BUY
$99.61 - $142.12 $6.08 Million - $8.67 Million
61,000 Added 14.39%
485,000 $64.3 Million
Q1 2020

May 15, 2020

BUY
$37.9 - $104.44 $151,600 - $417,760
4,000 Added 0.95%
424,000 $24.6 Million
Q4 2019

Feb 14, 2020

SELL
$77.66 - $99.74 $912,505 - $1.17 Million
-11,750 Reduced 2.72%
420,000 $38.8 Million
Q3 2019

Nov 14, 2019

BUY
$90.37 - $122.49 $3.14 Million - $4.26 Million
34,750 Added 8.75%
431,750 $39 Million
Q1 2019

May 15, 2019

BUY
$61.98 - $96.5 $743,760 - $1.16 Million
12,000 Added 3.12%
397,000 $34.4 Million
Q3 2018

Nov 14, 2018

BUY
$48.29 - $80.6 $241,450 - $403,000
5,000 Added 1.32%
385,000 $30.4 Million
Q2 2018

Aug 14, 2018

BUY
$37.84 - $69.96 $359,480 - $664,619
9,500 Added 2.56%
380,000 $22.7 Million
Q1 2018

May 15, 2018

SELL
$39.82 - $57.53 $2.56 Million - $3.7 Million
-64,400 Reduced 14.81%
370,500 $14.9 Million
Q4 2017

Feb 14, 2018

SELL
$46.49 - $60.51 $116,225 - $151,275
-2,500 Reduced 0.57%
434,900 $22.9 Million
Q3 2017

Nov 14, 2017

BUY
$37.05 - $47.12 $16.2 Million - $20.6 Million
437,400
437,400 $20.6 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.77B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.